InsiderClue
Insiders · Profile

Heffernan Michael Thomas

Director at Trevi Therapeutics · Director at COLLEGIUM PHARMACEUTICAL. Filing since 15 Nov 2017. CIK 0001448914

TRVI Trevi Therapeutics, Inc. Director · 2 trades COLL COLLEGIUM PHARMACEUTICAL, INC Director · 30 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TRVI Trevi Therapeutics, Inc.
15 Sep 2026
Director
Sold on a plan
39,473
$595.81K
86.1%
COLL COLLEGIUM PHARMACEUTICAL, INC
27 Dec 2022
Director
Sold, plan not stated
19,815
$470.25K
41.4%
COLL COLLEGIUM PHARMACEUTICAL, INC
23 Dec 2022
Director
Sold, plan not stated
4,989
$114.75K
15.1%
COLL COLLEGIUM PHARMACEUTICAL, INC
22 Dec 2022
Director
Sold, plan not stated
237
$5.45K
0.8%
COLL COLLEGIUM PHARMACEUTICAL, INC
21 Dec 2022
Director
Sold, plan not stated
46,600
$1.08M
62.4%
COLL COLLEGIUM PHARMACEUTICAL, INC
20 Dec 2022
Director
Sold, plan not stated
33,758
$779.13K
54.6%
COLL COLLEGIUM PHARMACEUTICAL, INC
19 Dec 2022
Director
Sold, plan not stated
3,606
$83.08K
11.4%
COLL COLLEGIUM PHARMACEUTICAL, INC
13 Dec 2022
Director
Sold, plan not stated
161,687
$3.58M
85.2%
COLL COLLEGIUM PHARMACEUTICAL, INC
12 Dec 2022
Director
Sold, plan not stated
27,920
$614.52K
49.9%
COLL COLLEGIUM PHARMACEUTICAL, INC
15 Mar 2021
Director
Sold, plan not stated
50,075
$1.27M
92.5%
COLL COLLEGIUM PHARMACEUTICAL, INC
11 Aug 2020
Director
Sold, plan not stated
13,071
$250.05K
19.5%
COLL COLLEGIUM PHARMACEUTICAL, INC
13 May 2020
Director
Sold, plan not stated
19,254
$416.42K
19.1%
COLL COLLEGIUM PHARMACEUTICAL, INC
21 Jan 2020
Director
Sold, plan not stated
295,287
$6.48M
73.4%
COLL COLLEGIUM PHARMACEUTICAL, INC
15 Jul 2019
Director
Sold, plan not stated
25,000
$281.50K
15.9%
COLL COLLEGIUM PHARMACEUTICAL, INC
17 Jun 2019
Director
Sold, plan not stated
25,000
$284.25K
13.7%
COLL COLLEGIUM PHARMACEUTICAL, INC
15 May 2019
Director
Sold, plan not stated
25,000
$321.04K
12.1%
TRVI Trevi Therapeutics, Inc.
9 May 2019
Director
Bought
2,500
$25.00K
64.9%
COLL COLLEGIUM PHARMACEUTICAL, INC
15 Apr 2019
Director
Sold, plan not stated
25,000
$377.37K
11.0%
COLL COLLEGIUM PHARMACEUTICAL, INC
15 Mar 2019
Director
Sold, plan not stated
25,000
$429.25K
9.9%
COLL COLLEGIUM PHARMACEUTICAL, INC
15 Feb 2019
Director
Sold, plan not stated
25,000
$370.22K
9.0%
COLL COLLEGIUM PHARMACEUTICAL, INC
15 Jan 2019
Director
Sold, plan not stated
25,000
$389.00K
8.0%
COLL COLLEGIUM PHARMACEUTICAL, INC
17 Dec 2018
Director
Sold, plan not stated
25,000
$454.49K
7.4%
COLL COLLEGIUM PHARMACEUTICAL, INC
15 Nov 2018
Director
Sold, plan not stated
25,000
$415.12K
6.9%
COLL COLLEGIUM PHARMACEUTICAL, INC
15 Oct 2018
Director
Sold, plan not stated
25,000
$413.25K
6.5%
COLL COLLEGIUM PHARMACEUTICAL, INC
12 Jun 2018
Chairman, President and CEO
Sold, plan not stated
53,057
$1.34M
12.0%
COLL COLLEGIUM PHARMACEUTICAL, INC
11 Jun 2018
Chairman, President and CEO
Sold, plan not stated
96,943
$2.45M
18.0%
COLL COLLEGIUM PHARMACEUTICAL, INC
10 May 2018
Chairman, President and CEO
Sold, plan not stated
7,100
$186.10K
1.3%
COLL COLLEGIUM PHARMACEUTICAL, INC
19 Apr 2018
Chairman, President and CEO
Sold, plan not stated
44,400
$1.15M
7.5%
COLL COLLEGIUM PHARMACEUTICAL, INC
23 Jan 2018
Chairman, President and CEO
Sold, plan not stated
16,408
$410.36K
3.1%
COLL COLLEGIUM PHARMACEUTICAL, INC
22 Jan 2018
Chairman, President and CEO
Sold, plan not stated
3,592
$89.80K
0.7%
COLL COLLEGIUM PHARMACEUTICAL, INC
19 Jan 2018
Chairman, President and CEO
Sold, plan not stated
20,000
$450.00K
3.6%
COLL COLLEGIUM PHARMACEUTICAL, INC
15 Nov 2017
Chairman, President and CEO
Sold, plan not stated
50,000
$776.50K
8.2%
32 decisions on file.